USA – IVX Health has announced that it has completed US$ 100 million from Great Hill Partners in a Series F investment round to accelerate its entry into new markets and make its outpatient infusion centers the nation’s preferred pharmaceutical care destinations for patients with chronic conditions.
IVX, an intensive care infusion company, was founded in 2012 and has ever since grown to more than 50 infusion centers in 16 markets in the United States.
It is a national provider of infusion and injection therapy as an alternative to hospital-based services treating Multiple sclerosis, Crohn’s disease, and rheumatoid arthritis are among the complex conditions.
According to Crunchbase, the company has raised US$136.3 million to date in funding over 4 rounds and is funded by 6 investors with Great Hill Partners and Nueterra Capital being the most recent investors.
Additionally, IVX Health has a post-money valuation in the range of US$100M to US$500M as of Aug 6, 2019, according to PrivCo.
IVX Health plans to use the Series F funds to expand its branches across the country and provide unmatched healthcare services to its clients.
The company seeks to provide an alternative to hospital infusion and infusion services through a convenient, cost-effective care location that guarantees private suites and flexible scheduling on request, including evenings and weekends.
The financial injection will help IVX Health to provide even better services in line with its goals.
“Our primary goal has always been to provide world-class service and clinical excellence to the patients we serve,” said Doug Ghertner, CEO of IVX Health, in a statement. “IVX and Great Hill both see an inflection point in infusion therapy, as the growth in diagnosed autoimmune conditions and trends toward patient choice have aligned with an uptick in innovative new therapies.”
Many patients are still left with few options for receiving infusion and injection therapy, often in a hospital’s overcrowded infusion room.
The funding has come at a prime time to help IVX Health ease the burden of overcrowding in its clinics and catapult it to its next phase of growth as it seeks to enter new markets and partner with other providers in the healthcare sector while continuing to redefine patient care experience and referring providers.